Healthcare provider profile · identity verified

John Wisneski

Internal Medicine · ASPINWALL, PA · NPI 1245206325

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	667	199
Atorvastatin Calcium	Atorvastatin Calcium	629	172
Levothyroxine Sodium	Levothyroxine Sodium	508	126
Losartan Potassium	Losartan Potassium	445	142
Metoprolol Tartrate	Metoprolol Tartrate	323	81
Eliquis	Apixaban	302	64
Pantoprazole Sodium	Pantoprazole Sodium	274	75
Rosuvastatin Calcium	Rosuvastatin Calcium	260	84
Hydrochlorothiazide	Hydrochlorothiazide	255	83
Simvastatin	Simvastatin	242	79
Lisinopril	Lisinopril	224	75
Furosemide	Furosemide	220	72
Tamsulosin Hcl	Tamsulosin Hcl	218	65
Gabapentin	Gabapentin	208	65
Sertraline Hcl	Sertraline Hcl	196	57
Omeprazole	Omeprazole	177	58
Famotidine	Famotidine	169	52
Metoprolol Succinate	Metoprolol Succinate	166	50
Prednisone	Prednisone	161	46
Alprazolam	Alprazolam	143	48
Allopurinol	Allopurinol	138	34
Metformin Hcl	Metformin Hcl	135	52
Potassium Chloride	Potassium Chloride	126	30
Trazodone Hcl	Trazodone Hcl	113	34
Fluticasone Propionate	Fluticasone Propionate	101	35
Zolpidem Tartrate	Zolpidem Tartrate	100	25
Doxycycline Hyclate	Doxycycline Hyclate	86	73
Synthroid	Levothyroxine Sodium	86	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	83	14
Clopidogrel	Clopidogrel Bisulfate	82	21
Tramadol Hcl	Tramadol Hcl	82	24
Albuterol Sulfate Hfa	Albuterol Sulfate	80	26
Clonazepam	Clonazepam	79	15
Atenolol	Atenolol	78	25
Methylprednisolone	Methylprednisolone	78	65
Celecoxib	Celecoxib	76	24
Alendronate Sodium	Alendronate Sodium	73	20
Finasteride	Finasteride	73	22
Donepezil Hcl	Donepezil Hcl	72	25
Tradjenta	Linagliptin	71	13
Lorazepam	Lorazepam	62	17
Jantoven	Warfarin Sodium	60	suppressed
Meloxicam	Meloxicam	56	20
Hydralazine Hcl	Hydralazine Hcl	55	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	13
Carbidopa-Levodopa	Carbidopa/Levodopa	53	suppressed
Buspirone Hcl	Buspirone Hcl	52	15
Citalopram Hbr	Citalopram Hydrobromide	51	16
Levetiracetam	Levetiracetam	51	suppressed
Carvedilol	Carvedilol	50	16
Montelukast Sodium	Montelukast Sodium	49	17
Xarelto	Rivaroxaban	49	13
Jardiance	Empagliflozin	47	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	21
Bromocriptine Mesylate	Bromocriptine Mesylate	44	suppressed
Glipizide Er	Glipizide	40	14
Mirtazapine	Mirtazapine	40	11
Oxycodone Hcl	Oxycodone Hcl	39	12
Paxlovid	Nirmatrelvir/Ritonavir	36	35
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	11
Warfarin Sodium	Warfarin Sodium	35	12
Meclizine Hcl	Meclizine Hcl	31	12
Valsartan	Valsartan	31	suppressed
Amoxicillin	Amoxicillin	30	22
Ezetimibe	Ezetimibe	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	11
Bisoprolol Fumarate	Bisoprolol Fumarate	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	24
Ondansetron Odt	Ondansetron	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Azithromycin	Azithromycin	18	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Irbesartan	Irbesartan	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ozempic	Semaglutide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Ketoconazole	Ketoconazole	13	11
Memantine Hcl	Memantine Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Primidone	Primidone	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Juluca	Dolutegravir/Rilpivirine	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Naproxen	Naproxen	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error